Particle.news
Download on the App Store

CDC Panel Backs Scaling Back Hepatitis B Shot at Birth for Most Newborns

The recommendation now goes to the CDC director for formal adoption.

Overview

  • After two days of debate, the CDC’s vaccine advisory committee voted 8–3 to limit the birth‑dose Hepatitis B shot to cases where the infant or mother tests positive or the mother’s status is unknown.
  • For infants whose mothers test negative, the panel advises deferring the first Hepatitis B dose until at least two months after birth following discussion with a physician.
  • The American Academy of Pediatrics called the recommendation misleading for parents, with president Susan Kressly warning it would likely increase infections in infants and children.
  • Health Secretary Robert F. Kennedy Jr. reshaped the advisory panel in June with members described as vaccine skeptics and has questioned a possible vaccine–autism link, moves critics say influenced the outcome.
  • The White House said President Donald Trump welcomed the shift and directed a broader review of childhood vaccination rules to align with practices in comparable countries.